AI Article Synopsis
- - Eosinophilic gastrointestinal diseases, which are on the rise, have unclear causes and treatment options, particularly for adults.
- - The text discusses a specific case of eosinophilic gastroenteritis and colitis that also showed extraintestinal symptoms.
- - Successful treatment for this case involved the use of adalimumab, a tumor necrosis factor α inhibitor.
Article Abstract
Eosinophilic gastrointestinal diseases are increasing in prevalence, but understanding of their causes and effective treatments remain elusive, especially in adults. We present a case of eosinophilic gastroenteritis and colitis with extraintestinal manifestations that was successfully treated with a tumor necrosis factor α inhibitor, adalimumab.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10881084 | PMC |
| http://dx.doi.org/10.14309/crj.0000000000001285 | DOI Listing |
Publication Analysis
Top Keywords
successful treatment
4
treatment eosinophilic
4
eosinophilic enterocolitis
4
enterocolitis adult
4
adult patient
4
patient adalimumab
4
adalimumab eosinophilic
4
eosinophilic gastrointestinal
4
gastrointestinal diseases
4
diseases increasing
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!